Introduction: The effectiveness of probiotics in patients with abnormal glucose metabolism has not been clearly demonstrated. It is also unclear if outcomes are consistent across different probiotic formulations. Methods: A literature search was conducted using PubMed, EMBASE, and Cochrane CENTRAL database from inception through May 2020. Randomized controlled trials that evaluated the effect of probiotics on fasting blood glucose (FBG) or hemoglobin A1c (HbA1c) in patients with prediabetes, type 2 diabetes mellitus, or gestational diabetes were included. Outcomes of interest included FBG, HbA1c, fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), homeostatic model assessment of β-cell function (HOMA-B), and quantitative insulin sensitivity check index (QUICKI). Weighted mean difference (WMD) and 95% confidence intervals (CIs) were calculated using the DerSimonian and Laird random-effects model. Results: 31 studies involving 1,948 participants were included in this analysis. Compared to control, probiotics had a significant favorable effect on FBG (WMD −5.77 mg/dL, 95% CI −8.48 to −3.06), HbA1c (WMD −0.32%, 95% CI −0.47 to −0.18), fasting insulin (WMD −2.95 µIU/mL, 95% CI −3.76 to −2.14), HOMA-IR (WMD −0.82, 95% CI −1.05 to −0.59), HOMA-B (WMD −14.86, 95% CI −24.57 to −5.16), and QUICKI (WMD 0.015, 95% CI 0.011–0.019). Further, probiotics were associated with favorable outcomes on all parameters at doses between 1 and 10 × 109 colony-forming unit per day (p < 0.004 for all) and formulations containing 2–4 strains (p < 0.05 for all). Discussion/Conclusion: Probiotics appear to have a modest effect on glycemic parameters in patients with abnormal glucose metabolism. Due to the limited number of trials conducted in patients with prediabetes, more studies are warranted in this population.

1.
Boirivant
M
,
Strober
W
.
The mechanism of action of probiotics
.
Curr Opin Gastroenterol
.
2007
;
23
(
6
):
679
92
.
2.
Zhang
Q
,
Wu
Y
,
Fei
X
.
Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
.
Medicina
.
2016
;
52
(
1
):
28
34
. .
3.
Baothman
OA
,
Zamzami
MA
,
Taher
I
,
Abubaker
J
,
Abu-Farha
M
.
The role of gut microbiota in the development of obesity and diabetes
.
Lipids Health Dis
.
2016
;
15
:
108
.
4.
den Besten
G
,
van Eunen
K
,
Groen
AK
,
Venema
K
,
Reijngoud
DJ
,
Bakker
BM
.
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
.
J Lipid Res
.
2013
;
54
(
9
):
2325
40
.
5.
Zanchi
D
,
Depoorter
A
,
Egloff
L
,
Haller
S
,
Mählmann
L
,
Lang
UE
,
The impact of gut hormones on the neural circuit of appetite and satiety: a systematic review
.
Neurosci Biobehav Rev
.
2017
;
80
:
457
75
. .
6.
Mazloom
Z
,
Yousefinejad
A
,
Dabbaghmanesh
MH
.
Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial
.
Iran J Med Sci
.
2013
;
38
(
1
):
38
43
.
7.
Khalili
L
,
Alipour
B
,
Asghari Jafar-Abadi
M
,
Faraji
I
,
Hassanalilou
T
,
Mesgari Abbasi
M
,
The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-a levels in patients with type 2 diabetes mellitus: a randomized controlled trial
.
Iran Biomed J
.
2019
;
23
(
1
):
68
77
.
8.
Jafarnejad
S
,
Saremi
S
,
Jafarnejad
F
,
Arab
A
. E
ffects of a multispecies probiotic mixture on glycemic control and inflammatory status in women with gestational diabetes: a randomized controlled clinical trial
.
J Nutr Metab
.
2016
;
2016
:
5190846
.
9.
Badehnoosh
B
,
Karamali
M
,
Zarrati
M
,
Jamilian
M
,
Bahmani
F
,
Tajabadi-Ebrahimi
M
,
The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes
.
J Matern Fetal Neonatal Med
.
2018
;
31
(
9
):
1128
36
.
10.
Liberati
A
,
Altman
DG
,
Tetzlaff
J
,
Mulrow
C
,
Gøtzsche
PC
,
Ioannidis
JP
,
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
.
PLoS Med
.
2009
;
6
(
10
):
e1000100
34
. .
11.
Sterne
JAC
,
Savović
J
,
Page
MJ
,
Elbers
RG
,
Blencowe
NS
,
Boutron
I
,
RoB 2: a revised tool for assessing risk of bias in randomised trials
.
BMJ
.
2019
;
366
:
l4898
. .
12.
RoB2 Development Group
.
Current version of RoB 2 2019 [Internet]
. [cited 2020 Sep 10]. Available from: https://www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2.
13.
RoB 2.0 Working Group on Cross-over Trials
.
RoB 2 for crossover trials 2016 [Internet]
. [cited 2020 Oct 9]. Available from: https://www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-crossover-trials.
14.
The Cochrane Collaboration
.
Cochrane handbook for systematic reviews of interventions [Internet]
. [cited 2021 Jan 2]. Available from: https://handbook-5-1.cochrane.org/chapter_7/7_7_3_2_obtaining_standard_deviations_from_standard_errors_and.htm.
15.
Higgins
JP
,
Thompson
SG
,
Deeks
JJ
,
Altman
DG
.
Measuring inconsistency in meta-analyses
.
BMJ
.
2003
;
327
(
7414
):
557
60
.
16.
Hsieh
MC
,
Tsai
WH
,
Jheng
YP
,
Su
SL
,
Wang
SY
,
Lin
CC
,
The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial
.
Sci Rep
.
2018
;
8
(
1
):
16791
.
17.
Jamilian
M
,
Amirani
E
,
Asemi
Z
.
The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial
.
Clin Nutr
.
2019
;
38
(
5
):
2098
105
.
18.
Kassaian
N
,
Feizi
A
,
Aminorroaya
A
,
Jafari
P
,
Ebrahimi
MT
,
Amini
M
.
The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial
.
Acta Diabetol
.
2018
;
55
(
10
):
1019
28
.
19.
Mobini
R
,
Tremaroli
V
,
Ståhlman
M
,
Karlsson
F
,
Levin
M
,
Ljungberg
M
,
Metabolic effects of lactobacillus reuteri DSM 17938 in people with type 2 diabetes: a randomized controlled trial
.
Diabetes Obes Metab
.
2017
;
19
(
4
):
579
89
. .
20.
Ahmadi
S
,
Jamilian
M
,
Tajabadi-Ebrahimi
M
,
Jafari
P
,
Asemi
Z
.
The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial
.
Br J Nutr
.
2016
;
116
(
8
):
1394
401
.
21.
Asemi
Z
,
Alizadeh
SA
,
Ahmad
K
,
Goli
M
,
Esmaillzadeh
A
.
Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: a double-blind randomized cross-over controlled clinical trial
.
Clin Nutr
.
2016
;
35
(
4
):
819
25
.
22.
Asemi
Z
,
Khorrami-Rad
A
,
Alizadeh
SA
,
Shakeri
H
,
Esmaillzadeh
A
.
Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial
.
Clin Nutr
.
2014
;
33
(
2
):
198
203
.
23.
Asemi
Z
,
Zare
Z
,
Shakeri
H
,
Sabihi
SS
,
Esmaillzadeh
A
.
Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes
.
Ann Nutr Metab
.
2013
;
63
(
1–2
):
1
9
.
24.
Babadi
M
,
Khorshidi
A
,
Aghadavood
E
,
Samimi
M
,
Kavossian
E
,
Bahmani
F
,
The effects of probiotic supplementation on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial
.
Probiotics Antimicrob Proteins
.
2019
;
11
(
4
):
1227
35
.
25.
Ebrahimi
ZS
,
Nasli-Esfahani
E
,
Nadjarzade
A
,
Mozaffari-Khosravi
H
.
Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial
.
J Diabetes Metab Disord
.
2017
;
16
:
23
.
26.
Firouzi
S
,
Majid
HA
,
Ismail
A
,
Kamaruddin
NA
,
Barakatun-Nisak
MY
.
Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial
.
Eur J Nutr
.
2017
;
56
(
4
):
1535
50
.
27.
Karamali
M
,
Dadkhah
F
,
Sadrkhanlou
M
,
Jamilian
M
,
Ahmadi
S
,
Tajabadi-Ebrahimi
M
,
Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial
.
Diabetes Metab
.
2016
;
42
(
4
):
234
41
.
28.
Kijmanawat
A
,
Panburana
P
,
Reutrakul
S
,
Tangshewinsirikul
C
.
Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: a double-blind randomized controlled trial
.
J Diabetes Investig
.
2019
;
10
(
1
):
163
70
.
29.
Kobyliak
N
,
Falalyeyeva
T
,
Mykhalchyshyn
G
,
Kyriienko
D
,
Komissarenko
I
.
Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial
.
Diabetes Metab Syndr
.
2018
;
12
(
5
):
617
24
.
30.
Lindsay
KL
,
Brennan
L
,
Kennelly
MA
,
Maguire
OC
,
Smith
T
,
Curran
S
,
Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial
.
Am J Obstet Gynecol
.
2015
;
212
(
4
):
496
11
. .
31.
Madempudi
RS
,
Ahire
JJ
,
Neelamraju
J
,
Tripathi
A
,
Nanal
S
.
Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: a double blind, randomized, placebo controlled study
.
PLoS One
.
2019
;
14
(
11
):
e0225168
.
32.
Mafi
A
,
Namazi
G
,
Soleimani
A
,
Bahmani
F
,
Aghadavod
E
,
Asemi
Z
.
Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial
.
Food Funct
.
2018
;
9
(
9
):
4763
70
.
33.
Mohseni
S
,
Bayani
M
,
Bahmani
F
,
Tajabadi-Ebrahimi
M
,
Bayani
MA
,
Jafari
P
,
The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial
.
Diabetes Metab Res Rev
.
2018
;
34
(
3
).
34.
Kobyliak
N
,
Falalyeyeva
T
,
Mykhalchyshyn
G
,
Molochek
N
,
Savchuk
O
,
Kyriienko
D
,
Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: a randomised controlled trial
.
Obes Med
.
2020
;
19
:
100248
.
35.
Nabhani
Z
,
Hezaveh
SJG
,
Razmpoosh
E
,
Asghari-Jafarabadi
M
,
Gargari
BP
.
The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: a randomized double blind placebo controlled clinical trial
.
Diabetes Res Clin Pract
.
2018
;
138
:
149
57
.
36.
Raygan
F
,
Ostadmohammadi
V
,
Asemi
Z
.
The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial
.
Clin Nutr
.
2019
;
38
(
4
):
1594
8
.
37.
Raygan
F
,
Ostadmohammadi
V
,
Bahmani
F
,
Asemi
Z
.
The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial
.
Prog Neuropsychopharmacol Biol Psychiatry
.
2018
;
84
(
Pt A
):
50
5
.
38.
Raygan
F
,
Rezavandi
Z
,
Bahmani
F
,
Ostadmohammadi
V
,
Mansournia
MA
,
Tajabadi-Ebrahimi
M
,
The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease
.
Diabetol Metab Syndr
.
2018
;
10
:
51
.
39.
Sheth
M
,
Chand
V
,
Thakuria
A
.
Inflated levels of SCFA, Bifidobacteria and Lactobacillus improves the status of pre hypertension and type 2 diabetes mellitus in subjects residing in north east India: A randomized control trial with synbiotic supplementation
.
Int J Curr Pharm Res
.
2015
;
7
:
33
6
.
40.
Soleimani
A
,
Motamedzadeh
A
,
Zarrati Mojarrad
M
,
Bahmani
F
,
Amirani
E
,
Ostadmohammadi
V
,
The effects of synbiotic supplementation on metabolic status in diabetic patients undergoing hemodialysis: a randomized, double-blinded, placebo-controlled trial
.
Probiotics Antimicrob Proteins
.
2019
;
11
(
4
):
1248
56
.
41.
Soleimani
A
,
Zarrati Mojarrad
M
,
Bahmani
F
,
Taghizadeh
M
,
Ramezani
M
,
Tajabadi-Ebrahimi
M
,
Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects
.
Kidney Int
.
2017
;
91
(
2
):
435
42
.
42.
Tajabadi-Ebrahimi
M
,
Sharifi
N
,
Farrokhian
A
,
Raygan
F
,
Karamali
F
,
Razzaghi
R
,
A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease
.
Exp Clin Endocrinol Diabetes
.
2017
;
125
(
1
):
21
7
.
43.
Taylor
BL
,
Woodfall
GE
,
Sheedy
KE
,
O'Riley
ML
,
Rainbow
KA
,
Bramwell
EL
,
Effect of probiotics on metabolic outcomes in pregnant women with gestational diabetes: a systematic review and meta-analysis of randomized controlled trials
.
Nutrients
.
2017
;
9
(
5
).
44.
Ardeshirlarijani
E
,
Tabatabaei-Malazy
O
,
Mohseni
S
,
Qorbani
M
,
Larijani
B
,
Baradar Jalili
R
.
Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials
.
Daru
.
2019
;
27
(
2
):
827
37
.
45.
Peng
TR
,
Wu
TW
,
Chao
YC
.
Effect of probiotics on the glucose levels of pregnant women: a meta-analysis of randomized controlled trials
.
Medicina
.
2018
;
54
(
5
). .
46.
Sherifali
D
,
Nerenberg
K
,
Pullenayegum
E
,
Cheng
JE
,
Gerstein
HC
.
The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis
.
Diabetes Care
.
2010
;
33
(
8
):
1859
64
.
47.
Ouwehand
AC
,
Invernici
MM
,
Furlaneto
FAC
,
Messora
MR
.
Effectiveness of multistrain versus single-strain probiotics: current status and recommendations for the future
.
J Clin Gastroenterol
.
2018
;
52 Suppl 1
:
S35
S40
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.